Literature DB >> 8622479

HMO formularies and care costs.

D Ross-Degnan, S B Soumerai.   

Abstract

Mesh：

Year:  1996        PMID： 8622479     DOI： 10.1016/s0140-6736(96)90782-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Rethinking prescribing in the United States.

Authors:  Andrew Ellner
Journal:  BMJ       Date:  2003-12-13

Review 2.  Pharmacy utilization and the Medicare Modernization Act.

Authors:  Vittorio Maio; Laura Pizzi; Adam R Roumm; Janice Clarke; Neil I Goldfarb; David B Nash; David Chess
Journal:  Milbank Q       Date:  2005       Impact factor: 4.911

Review 3.  Formulary restriction of selective serotonin reuptake inhibitors for depression: potential pitfalls.

Authors:  P L Hensley; H G Nurnberg
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

4.  Clinical and economic consequences of a reimbursement restriction of nebulised respiratory therapy in adults: direct comparison of randomised and observational evaluations.

Authors:  Sebastian Schneeweiss; Malcolm Maclure; Bruce Carleton; Robert J Glynn; Jerry Avorn
Journal:  BMJ       Date:  2004-02-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.